L'iceberg émerge Cas clinique Docteur Synapse

Références :
1. Grodzinsky E, Hed J, Skogh T. IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients. Allergy 1994; 49:593.

2. Uibo O, Uibo R, Kleimola V, et al. Serum IgA antigliadin antibodies in an adult population sample. High prevalence without celiac disease. Dig Dis Sci 1993; 38:2034.

3. Ferreira M, Davies SL, Butler M, et al. Endomysial antibody: is it the best screening test for coeliac disease? Gut 1992; 33:1633.

4. Mäki M. The humoral immune system in coeliac disease. Baillieres Clin Gastroenterol 1995; 9:231.

5. BürginWolff A, Gaze H, Hadziselimovic F, et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 1991; 66:941.

6. Chorzelski TP, Beutner EH, Sulej J, et al. IgA antiendomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 1984; 111:395.

7. Sugai E, Vázquez H, Nachman F, et al. Accuracy of testing for antibodies to synthetic gliadinrelated peptides in celiac disease. Clin Gastroenterol Hepatol 2006; 4:1112.

8. Prince HE. Evaluation of the INOVA diagnostics enzymelinked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol 2006; 13:150.

9. Hopper AD, Cross SS, Hurlstone DP, et al. Preendoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007; 334:729.

10. Hopper AD, Hadjivassiliou M, Hurlstone DP, et al. What is the role of serologic testing in celiac disease? A prospective, biopsyconfirmed study with economic analysis. Clin Gastroenterol Hepatol 2008; 6:314.

11. Tonutti E, Visentini D, Bizzaro N, et al. The role of antitissue transglutaminase assay for the diagnosis and monitoring of coeliac disease: a FrenchItalian multicentre study. J Clin Pathol 2003; 56:389.

12. Abrams JA, Brar P, Diamond B, et al. Utility in clinical practice of immunoglobulin a antitissue transglutaminase antibody for the diagnosis of celiac disease. Clin Gastroenterol Hepatol 2006; 4:726.

13. Cammarota G, Martino A, Pirozzi GA, et al. Direct visualization of intestinal villi by highresolution magnifying upper endoscopy: a validation study. Gastrointest Endosc 2004; 60:732.

14. Hurlstone DP, Sanders DS. Highmagnification immersion chromoscopic duodenoscopy permits visualization of patchy atrophy in celiac disease: an opportunity to target biopsies of abnormal mucosa. Gastrointest Endosc 2003; 58:815.

15. Lo A, Guelrud M, Essenfeld H, Bonis P. Classification of villous atrophy with enhanced magnification endoscopy in patients with celiac disease and tropical sprue. Gastrointest Endosc 2007; 66:377.

16. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992; 102:330.